Managing antithrombotic therapy in immune thrombocytopenia: development of the TH2 risk assessment score

Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP

(2015) A. L. Frelinger et al.   BLOOD

Risk of thromboembolism with thrombopoietin receptor agonists in adult patients with thrombocytopenia: Systematic review and meta-analysis of randomized controlled trials

(2015) Ferrán Catalá-López et al.   MEDICINA CLINICA

Atrial Fibrillation in Patients with Cryptogenic Stroke

(2014) David J. Gladstone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Deep vein thrombosis associated with a single dose of romiplostim in a high-risk patient

(2012) E. Przespo et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Antithrombotic Therapy for VTE Disease

(2012) Clive Kearon et al.   CHEST

Risk prediction models: II. External validation, model updating, and impact assessment

(2012) Karel G M Moons et al.   HEART

Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker

(2012) Karel G M Moons et al.   HEART

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

(2008) F. Rodeghiero et al.   BLOOD